Xenografting of Cancer Cell Lines for In Vivo Screening of the Therapeutic Potential of HDAC Inhibitors.

Methods Mol Biol

Department of Developmental Pathology, Institute of Pathology, University Medical School Bonn, Sigmund-Freud-Strasse 25, 53127, Bonn, Germany.

Published: January 2018

Histone deacetylase inhibitor application is lethal to many cancer types. To screen for the therapeutic potential of HDIs it is necessary to analyze their ability to target and kill cancer cells in vivo. Here, we describe the xenografting of (germ cell) cancer cell lines into the flank of nude mice and the subsequent intravenous application of HDIs.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-6527-4_15DOI Listing

Publication Analysis

Top Keywords

cancer cell
8
cell lines
8
therapeutic potential
8
xenografting cancer
4
lines vivo
4
vivo screening
4
screening therapeutic
4
potential hdac
4
hdac inhibitors
4
inhibitors histone
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!